NL264270A - - Google Patents

Info

Publication number
NL264270A
NL264270A NL264270DA NL264270A NL 264270 A NL264270 A NL 264270A NL 264270D A NL264270D A NL 264270DA NL 264270 A NL264270 A NL 264270A
Authority
NL
Netherlands
Application number
Publication of NL264270A publication Critical patent/NL264270A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/06Aluminium compounds
    • C07F5/069Aluminium compounds without C-aluminium linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
NL264270D NL264270A (en)

Publications (1)

Publication Number Publication Date
NL264270A true NL264270A (en)

Family

ID=1864713

Family Applications (1)

Application Number Title Priority Date Filing Date
NL264270D NL264270A (en)

Country Status (1)

Country Link
NL (1) NL264270A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2451713A (en) * 2007-02-06 2009-02-11 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2451713A (en) * 2007-02-06 2009-02-11 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
GB2451713B (en) * 2007-02-06 2009-12-16 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
US8058462B2 (en) 2007-02-06 2011-11-15 Medical Research Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation

Similar Documents

Publication Publication Date Title
US8058462B2 (en) Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
AU2001295589B2 (en) Regioselective liquid phase pegylation
AU1676992A (en) Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers
AU2004305291A1 (en) Branched polyethylene glycol for linking polymer residues to antibodies
ATE200030T1 (en) PEGYLATION PROCEDURE
ATE410432T1 (en) DIARYLPHENOXY ALUMINUM COMPOUNDS
AU2003251002B2 (en) Bisacyloxypropylcysteine conjugates and the use thereof
JP2010520856A5 (en)
ATE118686T1 (en) BIOLOGICALLY EFFECTIVE POLYMERIC DRUG DERIVATIVES.
AU2003263890A8 (en) Lewis acid ionic liquids
ATE533772T1 (en) SYNTHESIS OF BIGUANIDES AND TRIAZINES AND BIGUANINE-ALUMINUM COMPLEXES AS INTERMEDIATE PRODUCTS
ATE172216T1 (en) CONJUGATES OF CALCITONIN AND POLYETHYLENE GLYCOL
AT244989B (en) Process for the production of aluminum isopropoxide
AR207022A1 (en) PROCEDURE FOR THE PREPARATION OF POLY-N-DIMETHYLIMINOALANE
AU2002363791A1 (en) Protease enzyme inhibitors
ATE120373T1 (en) NON-SPECIFIC IMMUNOMODULATOR AGENT AND METHOD FOR THE PRODUCTION THEREOF.
AU1270101A (en) Interferon gamma conjugates
NL264270A (en)